NGLFINEPharmaceuticals
NGL Fine Chem Ltd — Profit & Loss Statement
₹2057.10
-5.32%
NGL Fine Chem Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.12 Cr | 1.76 Cr | 0.00 | 0.00 |
| Tax Rate For Calcs | 0.24 | 0.24 | 0.25 | 0.25 |
| Normalized EBITDA | 41.99 Cr | 60.08 Cr | 39.85 Cr | 78.53 Cr |
| Total Unusual Items | 0.51 Cr | 7.32 Cr | 0.00 | 0.00 |
| Total Unusual Items Excluding Goodwill | 0.51 Cr | 7.32 Cr | 0.00 | 0.00 |
| Net Income From Continuing Operation Net Minority Interest | 21.12 Cr | 41.32 Cr | 20.50 Cr | 49.90 Cr |
| Reconciled Depreciation | 12.45 Cr | 11.64 Cr | 11.29 Cr | 10.37 Cr |
| Reconciled Cost Of Revenue | 182.41 Cr | 158.69 Cr | 140.32 Cr | 146.99 Cr |
| EBITDA | 42.50 Cr | 67.40 Cr | 39.85 Cr | 78.53 Cr |
| EBIT | 30.05 Cr | 55.76 Cr | 28.56 Cr | 68.16 Cr |
| Net Interest Income | -2.66 Cr | -1.21 Cr | -1.59 Cr | -1.74 Cr |
| Interest Expense | 2.33 Cr | 1.34 Cr | 1.20 Cr | 1.56 Cr |
| Interest Income | 0.60 Cr | 0.60 Cr | 0.25 Cr | 0.18 Cr |
| Normalized Income | 20.74 Cr | 35.76 Cr | 20.50 Cr | 49.90 Cr |
| Net Income From Continuing And Discontinued Operation | 21.12 Cr | 41.32 Cr | 20.50 Cr | 49.90 Cr |
| Total Expenses | 340.60 Cr | 291.61 Cr | 249.91 Cr | 255.00 Cr |
| Selling General And Administration | 18.01 Cr | 16.18 Cr | 13.43 Cr | 14.87 Cr |
| Selling And Marketing Expense | 10.95 Cr | 9.97 Cr | 7.96 Cr | 11.03 Cr |
| General And Administrative Expense | 7.06 Cr | 6.21 Cr | 5.48 Cr | 3.84 Cr |
| Rent And Landing Fees | 2.81 Cr | 2.03 Cr | 1.58 Cr | 1.43 Cr |
| Gross Profit | 180.62 Cr | 175.03 Cr | 133.25 Cr | 165.84 Cr |
| Cost Of Revenue | 182.41 Cr | 158.69 Cr | 140.32 Cr | 146.99 Cr |
| Total Revenue | 363.03 Cr | 333.71 Cr | 273.57 Cr | 312.83 Cr |
| Operating Revenue | 363.03 Cr | 333.71 Cr | 273.57 Cr | 312.83 Cr |
| Rent Expense Supplemental | 2.81 Cr | 2.03 Cr | 1.58 Cr | 1.43 Cr |
| Diluted Average Shares | 0.62 Cr | 0.62 Cr | 0.62 Cr | 0.62 Cr |
| Basic Average Shares | 0.62 Cr | 0.62 Cr | 0.62 Cr | 0.62 Cr |
| Diluted EPS | 34.19 | 66.88 | 33.18 | 80.77 |
| Basic EPS | 34.19 | 66.88 | 33.18 | 80.77 |
| Diluted NI Availto Com Stockholders | 21.12 Cr | 41.32 Cr | 20.50 Cr | 49.90 Cr |
| Net Income Common Stockholders | 21.12 Cr | 41.32 Cr | 20.50 Cr | 49.90 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 21.12 Cr | 41.32 Cr | 20.50 Cr | 49.90 Cr |
| Net Income Including Noncontrolling Interests | 21.12 Cr | 41.32 Cr | 20.50 Cr | 49.90 Cr |
| Net Income Continuous Operations | 21.12 Cr | 41.32 Cr | 20.50 Cr | 49.90 Cr |
| Tax Provision | 6.59 Cr | 13.10 Cr | 6.87 Cr | 16.70 Cr |
| Pretax Income | 27.71 Cr | 54.42 Cr | 27.36 Cr | 66.60 Cr |
| Other Non Operating Income Expenses | 4.39 Cr | 2.25 Cr | 1.89 Cr | 5.72 Cr |
| Special Income Charges | -0.09 Cr | 0.00 | 0.00 | 0.00 |
| Write Off | 0.09 Cr | 0.00 | 0.00 | 0.00 |
| Net Non Operating Interest Income Expense | -2.66 Cr | -1.21 Cr | -1.59 Cr | -1.74 Cr |
| Total Other Finance Cost | 0.92 Cr | 0.47 Cr | 0.64 Cr | 0.35 Cr |
| Interest Expense Non Operating | 2.33 Cr | 1.34 Cr | 1.20 Cr | 1.56 Cr |
| Interest Income Non Operating | 0.60 Cr | 0.60 Cr | 0.25 Cr | 0.18 Cr |
| Operating Income | 22.43 Cr | 42.10 Cr | 23.67 Cr | 57.83 Cr |
| Operating Expense | 158.20 Cr | 132.93 Cr | 109.59 Cr | 108.01 Cr |
| Other Operating Expenses | 74.61 Cr | 62.93 Cr | 50.92 Cr | 51.16 Cr |
| Depreciation And Amortization In Income Statement | 12.45 Cr | 11.64 Cr | 11.29 Cr | 10.37 Cr |
| Depreciation Income Statement | 12.45 Cr | 11.64 Cr | 11.29 Cr | 10.37 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on NGL Fine Chem Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.